home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  July 19, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 456 active entries

InVivo BioTech Services GmbH

Neuendorfstr. 24a
16761 Hennigsdorf bei Berlin

Phone: +49 (0)3302 866 930
Fax: +49 (0)3302 866 9362
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it


InVivo BioTech Services GmbH is one of the leading contract manufacturing organizations in Europe, with more 25 years of experience in mammalian cell culture and protein production.

InVivo offers monoclonal antibody production from hybridoma cell lines exclusively under serum-free conditions using the proprietary ISF-1 medium. Moreover, a set of additional services such as hybridoma development, antibody labelling, antibody sequencing and cell banking are provided.

InVivo’s service portfolio also includes the production of recombinant antibodies and proteins from various different expression systems, including mammalian cells (HEK or CHO) and bacterial cells. This allows us to offer a suitable expression system for each specific customer project.

InVivo is also pleased to announce that we are launching our online store. There you will find our high quality products. Check our competitive prices at https://lnkd.in/e7_am578.

Our goal is to create lasting relationships by providing outstanding services and highly customized solutions to every client`s needs. As ISO 9001 and ISO 13485 certified company, we always aim for the highest quality standard. 


Selected Categories:
Product Company   Service Company
- Immunoassay
- in vitro
- Production
- Research
- Services

Last update of this entry: March 12, 2024

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.